A US news anchor who was encouraged to have a mammogram live on television by her producers discovered she had breast cancer from the test.
Hundreds of lives could be saved every year if breast cancer patients took their full five-year course of drugs, according to research.
As mourners lined the streets at the funeral of Bernie Nolan they were told not to cry too much.
Plain cigarette packaging should be introduced to help lower the amount of people dying from lung cancer, a leading health charity has said.
Macmillan Cancer Support made the renewed call for the reintroduction of the controversial policy, amid a Government review into the effectiveness of plain packaging.
Chief executive of Macmillan Cancer Support, Ciaran Devane said:
– Chief executive of Macmillan Cancer Support Ciaran Devane
Lung cancer patients deserve better. It is high time we closed the gap between survival rates for different cancers and give everyone the best possible chance of recovery.
Firstly, we support the call for plain packaging of cigarettes to stop people taking up smoking, secondly we must catch the illness earlier through better awareness and we have to make sure access to surgery is more uniform across the country to reduce inequalities in cancer survival.
It cannot be right that you are much more likely to get the surgery you need if you live in Leicestershire than if you live in Lancashire.
The number of people dying from three common cancers - breast, prostate and bowel - is expected to almost halve by the end of the decade, according to findings from a leading health charity.
Over a third, 36%, of breast cancer sufferers will succumb to the disease, a 61% drop in the mortality rate from 1992, Macmillian Cancer Support found.
A further 39% of people with bowel cancer would die, down from 67% in 1992.
However, the lung cancer mortality rate remains high, with 76% of patients expected to die from the disease, compared to 91% in 1992.
Professor Jane Maher, chief medical officer of Macmillan Cancer Support, said: "People diagnosed with three of the four most common cancers are more likely to survive but GPs need more support to help them diagnose lung cancer earlier."
More people are surviving cancer than ever before, but we want to become the best in Europe on survival rates. We know much more can be done to diagnose and treat cancer earlier.
We are spending £450 million to help diagnose cancer earlier, which will save thousands of extra lives every year, and we are investing more than £170 million over four years to expand and introduce pioneering new methods of screening for cancer.
– Department of Health spokesman
We are also committed to reducing inequalities in cancer care - that's why our Be Clear On Cancer campaigns are aimed at more disadvantaged groups and try to build awareness of cancer symptoms.
Women should go and see their GP at the earliest opportunity for a check-up, according to Cancer Research UK.
Experts have warned hundreds of poor women in England die needlessly from breast cancer every year.
Reacting to the new study, Dr Julie Sharp, head of health information at Cancer Research UK, said:
– Dr Julie Sharp, head of health information at Cancer Research UK
Other research shows that women from deprived backgrounds are more likely to feel embarrassed or worried about going to their GP - but it's important for women to take that step as going to the GP promptly could make all the difference.
All women should be aware of how their breasts normally look and feel because we know that early diagnosis is one of the most important factors in whether breast cancer treatment is effective.
Researchers based at the Universities of Leicester and Cambridge analysed how advanced breast cancer was in over 20,000 women diagnosed between 2006-2010 using data from the National Cancer Registration Service.
They then calculated how many lives could be saved with five years of diagnosis if the stage at diagnosis for poorer women matched those of the most affluent women.
If these socio-economic differences were removed, the equivalent of around 450 lives would be saved in England every year, they said.
– Dr Gary Abel, statistician at the University of Cambridge and study author.
These avoidable deaths are not due to differences in the response to treatment, or the type of breast cancer.
Hundreds of poor women in England die needlessly from breast cancer every year, experts have warned.
There are around 450 avoidable deaths among women from deprived areas each year, a study suggests.
The excess deaths occur because women from poorer backgrounds tend to be diagnosed with breast cancer when the disease is more advanced, the study's authors said.
The inequality between rich and poor breast cancer patients could arise because women from lower income groups are less aware of the symptoms of the disease and are more reluctant to see their GP, the authors told the National Cancer Research Institute Cancer Conference in Liverpool.
Baroness Morgan said:
The days of one size fits all treatment are well and truly in the past.
We need to ensure the life-saving and life-extending treatments we already have in the clinic are used more effectively - directing the right treatments to those who will benefit, and sparing others from unnecessary side effects, so that by 2050 we can achieve our ambition to overcome breast cancer.
A new breast cancer test identifies seven classes of the disease, defined by different combinations and levels of 10 proteins found in breast cancer cells.
The technology needed to measure the proteins in tumour samples already exists in most pathology laboratories across the UK, lead researcher Dr Andy Green, from the University of Nottingham, said.
A new test that identifies seven distinct types of breast cancer offers new hope to women with the disease, scientists claim.
The tumour sample test could be available within two years and is expected to lead to more personalised treatments.
Identifying more biomarkers will help doctors tailor therapy plans that better suit their patients, avoiding over or under treatment, they said.
Scientists funded by the Breast Cancer Campaign looked for signature biomarkers in 1,073 tumour samples from the charity's tissue bank. They found that 93% fitted perfectly into one of seven classes. Another 7% had mixed characteristics and were harder to categorise.